ten patients with active acromegaly , six with a poor response to previous therapies and four newly diagnosed , were treated with the long-acting somatostatin analog octreotide ( sandostatin ; 200-500 micrograms/day , sc , twice or three times daily ) for 6-15 months .
C0001206
acromegaly
C0028833
octreotide